Online citations, reference lists, and bibliographies.

Interpregnancy Interval And Birth Defects.

Adel Mburia-Mwalili, W. Yang
Published 2015 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
BACKGROUND Interpregnancy interval is a risk factor for various adverse birth outcomes including birth defects. We investigated the relationship between interpregnancy interval and birth defects. METHODS We conducted a retrospective cohort study using linked data from Nevada Birth Outcomes Monitoring System and birth certificate data for 124,341 singleton live births, of which 4641 infants had 7192 birth defects, among Nevada resident women between 2006 and 2011. We used logistic regression to assess factors independently associated with birth defects. RESULTS Women who had an interpregnancy interval of 36 months or more, adjusted odds ratio (AOR) = 1.16, 95% confidence interval [CI], 1.01-1.33, were more likely to have an infant with a birth defect compared with women with an interpregnancy interval of 18 to 23 months. Other independent risk factors for birth defects included male infants, AOR = 1.34, 95% CI, 1.26-1.42; maternal age (30-34 years) and advanced maternal age (35 years and older), AOR = 1.10, 95% CI, 1.01-1.19 and AOR = 1.29, 95% CI, 1.18-1.42, respectively; being a Black woman, AOR = 1.46, 95% CI, 1.32-1.61; three and four or more previous births, AOR = 1.12, 95% CI, 1.02-1.23 and AOR = 1.24, 95% CI, 1.11-1.38, respectively; smoking, AOR = 1.23, 95% CI, 1.10-1.38; and prescription drug use, AOR = 1.14, 95% CI, 1.07-1.21. CONCLUSION A long interpregnancy interval is an independent risk factor for birth defects. It may be helpful for maternal and child health programs and health care providers to highlight the deleterious effects of a long interpregnancy interval.
This paper references
10.1017/S1047951108002515
The importance of nomenclature for congenital cardiac disease: implications for research and evaluation.
M. Strickland (2008)
10.2105/AJPH.2013.301416
Shifts in intended and unintended pregnancies in the United States, 2001-2008.
L. Finer (2014)
10.2105/AJPH.2014.302098
The association between race/ethnicity and major birth defects in the United States, 1999-2007.
M. Canfield (2014)
pregnancies in Finland
MD Reller (2008)
10.1136/jech-2013-202991
Smoking cessation in the first trimester reduces most obstetric risks, but not the risks of major congenital anomalies and admission to neonatal care: a population-based cohort study of 1 164 953 singleton pregnancies in Finland
S. Räisänen (2013)
10.1586/17512433.2013.827401
The need for safer medication use in pregnancy
M. Honein (2013)
10.1177/003335491212700106
Racial/Ethnic Variations in the Prevalence of Selected Major Birth Defects, Metropolitan Atlanta, 1994–2005
James E. Kucik (2012)
10.1016/j.jpeds.2008.05.059
Prevalence of congenital heart defects in metropolitan Atlanta, 1998-2005.
M. Reller (2008)
10.1038/jp.2011.49
Relationship between interpregnancy interval and birth defects in Washington State
S. Kwon (2012)
10.1093/OXFORDJOURNALS.AJE.A010236
Prior spontaneous abortion, prior elective termination, interpregnancy interval, and risk of neural tube defects.
K. Todoroff (2000)
Facts about birth defects
GS Jhangri (2014)
10.1038/nrcardio.2010.166
The changing epidemiology of congenital heart disease
T. V. D. Bom (2011)
10.1111/ppe.12075
Maternal periconceptional exposure to cigarette smoking and congenital limb deficiencies.
Kristin M. Caspers (2013)
10.1016/j.ajog.2014.02.003
Interpregnancy interval and congenital anomalies.
S. Dolan (2014)
10.1016/j.contraception.2009.06.006
Effect of interpregnancy interval on adverse perinatal outcomes--a national study.
S. Grisaru-Granovsky (2009)
pregnancy and risk for congenital malformations: results of a Danish register-based cohort study
DR Martelli (2010)
10.1016/j.ajog.2014.02.002
Relationship between interpregnancy interval and congenital anomalies.
I. Chen (2014)
Cardiol Young 18(Suppl 2):92–100
K Todoroff (2000)
10.1111/J.1552-6909.2006.00016.X
The reliability and validity of birth certificates.
S. Northam (2006)
10.1002/bdra.23218
Sex prevalence of major congenital anomalies in the United Kingdom: A national population-based study and international comparison meta-analysis
Rachel Sokal (2014)
10.1590/S1808-86942010000100018
Maternal and paternal age, birth order and interpregnancy interval evaluation for cleft lip-palate.
Daniella Reis Barbosa Martelli (2010)
10.1093/aje/kwn065
Risk of oral clefts in relation to prepregnancy weight change and interpregnancy interval.
E. Villamor (2008)
10.1002/bdra.23061
Short interpregnancy interval and gastroschisis risk in the National Birth Defects Prevention Study.
Kelly D Getz (2012)
10.1016/j.jpeds.2009.07.058
Variation in the prevalence of congenital heart defects by maternal race/ethnicity and infant sex.
W. Nembhard (2010)
10.1055/b-0034-77864
[Congenital anomalies].
H. Nishimura (1967)
10.1111/aogs.12433
Maternal smoking in pregnancy and risk for congenital malformations: results of a Danish register‐based cohort study
M. Leite (2014)
10.1161/CIRCULATIONAHA.106.183216
Noninherited Risk Factors and Congenital Cardiovascular Defects: Current Knowledge: A Scientific Statement From the American Heart Association Council on Cardiovascular Disease in the Young
K. Jenkins (2007)
10.1056/NEJM199902253400801
Effect of the interval between pregnancies on perinatal outcomes.
B. P. Zhu (1999)
Otorhinolaryngol 76:107–112
J for cleft lip-palate. Braz (2004)
pregnancy interval and congenital anomalies
JR Daw (2011)
10.1093/phr/116.S1.32
The National Birth Defects Prevention Study
P. Yoon (2001)
10.1002/cpt.380
Medication use in pregnancy and the pregnancy and lactation labeling rule
L. Şahin (2016)
10.1002/pds.2184
Prescription drug use during pregnancy in developed countries: a systematic review.
Jamie R Daw (2011)
10.1023/A:1025492512915
Validation of Birth Certificate Data in New York State
P. Roohan (2004)
10.1016/j.ijgo.2004.08.002
Effect of interpregnancy interval on birth outcomes: findings from three recent US studies
B-P Zhu (2005)
Cardiovascular Disease in the Young: endorsed by the American Academy of Pediatrics. Circulation 115:2995–3014
KD Kochanek (2014)
The Congenital Heart Disease Genetic Network Study Rationale , Design , and Early Results
Sridhar Circ Res
10.1002/ajmg.c.30313
Evolving knowledge of the teratogenicity of medications in human pregnancy
M. Adam (2011)
10.1037/e510072014-001
The Health consequences of smoking—50 years of progress : a report of the Surgeon General
B. Lushniak (2014)



This paper is referenced by
Semantic Scholar Logo Some data provided by SemanticScholar